Dual-Energy X-ray Absorptiometry (DEXA): Nursing Guide
Dual-energy X-ray absorptiometry quantifies bone mineral density at standard sites to classify osteoporosis risk — nurses confirm indication and scan validity (calcium hold, metal removal, pregnancy screen), support safe positioning, and act on T-scores with fall prevention and fracture escalation when symptoms outpace imaging timing.
Contents
Quick Facts
Key Takeaway
With DXA, nursing judgment starts before the patient lies on the table: verify indication, calcium supplement hold, metal and prosthesis documentation, pregnancy status, and recent barium or contrast that may delay spine.
Imaging Parameters & Safety
Nurse quick-reference for imaging prep, safety screening, and transport.
Dual-energy X-ray absorptiometry (DEXA / DXA)
Not applicable — DXA does not use iodinated or oral contrast
Uses low-dose ionising radiation; dose is small relative to many CT protocols (equipment-dependent)
Acquisition often a few minutes; visit time includes registration and positioning
Usually supine on a padded table; hip and spine regions imaged per protocol
No fasting usually required for routine central DXA; body-composition protocols may require overnight fast per local policy
What is Dual-Energy X-ray Absorptiometry (DEXA)?
Dual-Energy X-ray Absorptiometry (DEXA) (DXA) is a noninvasive imaging method that passes two X-ray energy beams through bone to calculate bone mineral density (BMD), most often at the lumbar spine and hip. international health authorities T-score categories derived from central DXA are widely used to classify low bone mass and estimate fragility fracture risk when combined with clinical factors.
Overview
DXA appears in rheumatology, endocrine, oncology survivorship, and primary-care bone-health pathways — including inpatients on methotrexate or glucocorticoids for rheumatoid arthritis. Nurses coordinate eligibility, preparation that preserves measurement accuracy, transport, pregnancy screening, and communication of osteoporosis range results to prescribers and patients.
A low T-score should trigger fracture-prevention teaching, not passive reassurance. Conversely, acceptable BMD does not exclude fragility fracture when the patient reports new back pain, kyphosis, or height loss. Pair DXA with calcium and renal panels when bone therapy is considered.
Confirm calcium supplements and calcium-containing antacids were held at least 24 hours, document hip hardware or spinal implants, remove metal from scan regions, and screen for pregnancy when policy requires. After DXA, reinforce fall precautions and ensure T-scores reach the prescriber — escalate severe acute back pain or neurologic symptoms per protocol.
DXA Measurement Validity, Radiation, and Osteoporosis Escalation Safety
DXA is low risk for most patients, but preparation errors, missed pregnancy screening, and overlooking acute fracture symptoms can harm outcomes. Osteoporosis-range T-scores require action — not passive reassurance.
- Calcium supplements or antacids taken within 24 hours of lumbar spine imaging
- Recent barium or contrast studies artifacting the spine without rescheduling
- Acute severe back pain or neurologic deficits booked only for routine outpatient DXA
- Recurrent injurious falls despite known low BMD — fall pathway not activated
Document: calcium-hold compliance, pregnancy screen, hardware/prosthesis notes, sites scanned, T-score communication, fall teaching, and escalation for red-flag symptoms.
What Dual-Energy X-ray Absorptiometry (DEXA) Can and Cannot Tell You
This test can help identify:
- Low bone mineral density and international health authorities T-score categories (normal, low bone mass, osteoporosis)
- Baseline BMD before antiresorptive or anabolic therapy and serial monitoring on treatment
- Fracture risk estimation when combined with age, sex, and clinical risk tools (e.g., FRAX where used)
- Progressive BMD loss in patients on long-term glucocorticoids or other bone-toxic medicines
This test cannot:
- Diagnose vertebral fracture morphology alone — additional imaging or clinical correlation may be needed
- Replace fall-prevention assessment or home safety evaluation
- Rule out future fractures when T-score is normal or improving on therapy
- Determine treatment plan alone — prescriber integrates history, labs, risk tools, and preferences
Nursing Verification Before DXA Acquisition
Verify
Clarify before proceeding when:
- Order does not match screening vs monitoring indication
- Patient took calcium or high-calcium antacids within 24 hours
- Barium or spinal contrast within institutional delay window
- Pregnancy cannot be excluded per policy
- Acute severe back or hip pain suggests fracture — may need urgent pathway first
- Patient cannot lie still or supine safely without plan
- Prior DXA on different scanner/site — clarify comparison method with radiology
Integrating T-scores, Z-scores, and Clinical Fracture Risk
Integrate DXA with fracture history, height loss, falls, glucocorticoid use, and osteoporosis medicines when available. Trends on serial densitometry matter for treatment monitoring.
| Clinical context | Pair with DXA | Nursing focus |
|---|---|---|
| RA on long-term prednisone | T-score −2.3 with height loss | Bone-protective therapy review, mineral adherence, fall prevention |
| Postmenopausal screening | T-score −2.7; no prior fracture | Treatment counseling, home safety, follow-up interval |
| On antiresorptive therapy | T-score improved from −2.6 to −2.0 | Reinforce adherence; continue falls surveillance |
| New thoracic pain | Prior normal DXA | Do not dismiss — escalate for vertebral fracture workup |
Prep Errors, Hardware, and Mobility at the Bedside
| Bedside point | Nursing note |
|---|---|
| Lunchtime calcium | Common inpatient prep miss — verify hold at bedside, not only clinic instructions |
| Multivitamins | Many contain calcium; confirm all sources including antacids |
| Hip prosthesis | Document side — opposite hip may be measured per radiology protocol |
| Height loss | Measure serial height; >2 cm loss may indicate vertebral fracture |
| Glucocorticoids | Chronic oral steroids accelerate bone loss — flag for bone-health pathway |
| False reassurance | Normal T-score does not eliminate fall fracture risk |
Inpatient and Outpatient DXA Coordination Workflow
Diagnostic safety badge: Routine diagnostic test — standard identification, preparation, and result-follow-up checks still apply; escalate when red-flag symptoms suggest fracture or neurologic compromise.
Check-before-test protocol
- Identity + indication + central vs peripheral order
- Calcium-hold and multivitamin/antacid review
- Pregnancy screen when required
- Barium/contrast timing and hardware documentation
- Metal removal, mobility plan, and fall-risk escort
Critical teach-back questions
- "Can you tell me why this bone density scan is being done?"
- "What medicines or supplements should you avoid for 24 hours before the test?"
- "Which symptoms should you report even if your last scan was normal?"
Care coordination: primary prescriber, radiology/densitometry, pharmacy, rheumatology/endocrinology, physical therapy, and fall-prevention services when indicated.
DEXA Quick Safety and Follow-up Checklist
- Was calcium held for at least 24 hours?
- Is pregnancy status documented when policy requires?
- Any recent barium or contrast that requires delay?
- Does the patient have new back pain, height loss, or injurious falls needing escalation?
- Has T-score been communicated with fall-prevention and treatment follow-up?
Why Dual-Energy X-ray Absorptiometry (DEXA) is Ordered
Clinicians order DXA to screen adults at elevated fracture risk, diagnose low bone mass, monitor antiresorptive or anabolic therapy, and quantify bone loss in patients on long-term glucocorticoids or other bone-toxic medicines.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Postmenopausal or age-related osteoporosis screening | Does this patient meet guideline-based screening criteria? | Supports baseline BMD, preventive counseling, and treatment when density is low. |
| Serial monitoring on osteoporosis pharmacotherapy | Is BMD responding as expected on therapy? | Tracks treatment effect; nurses reinforce adherence and scheduled follow-up densitometry. |
| Glucocorticoid-induced or inflammatory bone loss | Is chronic steroid or inflammatory disease accelerating bone loss? | Guides bone-protective therapy, calcium/vitamin D optimization, and fall prevention. |
| Prior fragility fracture or progressive height loss | Is low BMD contributing to ongoing fracture risk? | Pairs BMD with history and exam; acute symptoms may need urgent imaging beyond routine DXA timing. |
Contraindications and Precautions
DXA is generally deferred when pregnancy cannot be excluded, when recent barium or contrast would artifact the spine without adequate delay, or when the patient cannot lie supine safely. Nurses clarify with radiology rather than proceeding with preparation that invalidates results.
- Sudden severe thoracic or lumbar pain after cough, lift, or minimal trauma — possible vertebral fracture.
- New leg weakness, saddle anesthesia, or bowel/bladder dysfunction — escalate urgently per protocol.
- Inability to bear weight after hip injury — orthopedic pathway may precede outpatient DXA.
- Calcium tablets or high-calcium antacids within 24 hours can falsely elevate lumbar spine BMD.
- Hip prosthesis, spinal hardware, or metal over scan sites may require alternate measurement regions.
- Possible pregnancy — confirm status and follow institutional radiation policy.
- Progressive back pain with fever or neurologic change (possible infection, fracture, or cord compromise).
- Fall with hip pain and inability to weight-bear — urgent assessment before routine densitometry.
- Osteoporosis-range T-score with recurrent injurious falls — activate fall-prevention and prescriber review.
Patient Preparation
Most central DXA preparation is simple but directly affects validity. Follow the radiology order, institutional checklist, and prescribing clinician instructions.
Pre-test checksReview glucocorticoids, anticonvulsants, aromatase inhibitors, and other bone-toxic medicines when interpreting indication and follow-up — do not independently hold prescribed medicines for DXA unless authorized by policy or the responsible clinician. Document reconciliation and bone-health teaching.
Where the test is performed
This page is a Tests & Diagnostics guide for Dual-Energy X-ray Absorptiometry (DEXA). It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Dual-Energy X-ray Absorptiometry (DEXA) is performed in radiology or dedicated bone densitometry services. Nurses focus on screening indication, preparation that affects measurement validity, T-score and fracture-risk communication, and escalation when symptoms suggest acute fracture or neurologic compromise — not scanner operation.
Use the preparation, results, and nursing responsibility sections below for safety checks, interpretation, escalation, and documentation — not equipment operation or departmental imaging protocols.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
DXA reports BMD in g/cm² with international health authorities-based T-scores (and often Z-scores). Nurses integrate results with age, sex, fracture history, medicines, falls, and mineral metabolism — not the numeric score in isolation.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Normal bone density (international health authorities T-score) | T-score −1.0 or above (normal bone density per international health authorities) | Lower relative fracture risk than osteoporosis range; falls and comorbidities still matter | Reinforce fall prevention, calcium/vitamin D as ordered, and rescreen per guideline |
| Low bone mass range | T-score between −1.0 and −2.5 (low bone mass / osteopenia range) | Increased fracture risk; clinical risk tools may guide treatment | Ensure prescriber review, lifestyle teaching, and follow-up plan documented |
| Osteoporosis threshold (T-score) | T-score −2.5 or below (osteoporosis threshold) | High fracture risk; may prompt pharmacologic therapy and fall-prevention referral | Communicate result, reinforce adherence, monitor for new fractures and falls |
| Low Z-score for age (when reported) | Z-score −2.0 or below in premenopausal women or men under 50 (when reported) | May suggest secondary osteoporosis — warrants evaluation beyond T-score alone | Notify prescriber; support secondary-cause workup per local pathway |
Urgent Clinical Findings and Escalation
DXA does not generate laboratory critical values, but certain clinical findings during scheduling or after positioning require urgent action independent of BMD.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Suspected acute vertebral or hip fracture | Severe localized pain, deformity, or inability to bear weight | Stop routine outpatient pathway; escalate for imaging/orthopedic evaluation per protocol |
| Neurologic deficit with back pain | Leg weakness, numbness, bowel/bladder dysfunction | Activate local emergency response per protocol; do not delay for scheduled DXA |
| Recurrent injurious falls | Fall with injury despite known low BMD or prior normal DXA | Assess injury, notify prescriber, initiate fall-prevention and fracture pathway |
Stop routine workflow and escalate according to facility policy when the patient develops acute severe back or hip pain, neurologic deficits, inability to mobilize safely, or falls with injury — even if prior DXA was normal or today’s scan is not yet reported.
Factors Affecting Results
BMD and T-scores may be influenced by patient factors, technique, supplements, prior imaging, and anthropometrics.
- Aortic calcification or vertebral osteophytes may falsely increase spine BMD
- Recent calcium ingestion within 24 hours may artifact lumbar measurement
- Hip arthroplasty or spinal hardware limits standard sites
- Peripheral heel/wrist DXA may not reflect central hip/spine fracture risk as well
- Single BMD measurement cannot predict every future fracture — clinical risk factors remain important
- Very low body weight or marked scoliosis may complicate spine interpretation
- Recent barium or spinal contrast — often requires 10–14 day delay
- Metal objects, dense clothing, or orthotics over the scan region
- Different scanner or facility compared with prior study — compare trends cautiously
DXA measures BMD, not bone microarchitecture or quality. It does not diagnose vertebral fracture morphology alone — additional imaging may be needed when morphology is suspected. Peripheral devices may screen but central spine/hip DXA is preferred for many treatment decisions. All results require clinical context.
Nursing Responsibilities
Nursing care emphasizes valid preparation, safe transport, fracture-risk communication, fall prevention, and timely follow-up on low T-scores.
Before the TestDocumentation
Clear documentation supports fracture-prevention continuity and audit trails.
“Central DXA lumbar spine and right hip (left hip prosthesis) completed at 1415. Calcium supplements held >24 h verified. Pregnancy screen N/A. Metal removed; patient tolerated supine positioning. T-score −2.4 lumbar spine communicated to rheumatology: osteoporosis range. Fall-prevention teaching provided; patient verbalized plan to use night-light and non-skid footwear.”
- Indication, order verification, and scan date/time
- Preparation (calcium hold, metal removal, pregnancy screen, hardware)
- Sites imaged and patient tolerance
- T-score/Z-score summary and prescriber notification
- Fall-prevention and treatment teaching provided
- Follow-up scan interval or referral plans
Patient and Family Education
Use plain language while emphasizing preparation, what the scan feels like, and symptoms that require immediate reporting.
Dual-Energy X-ray Absorptiometry (DEXA) NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Dual-Energy X-ray Absorptiometry (DEXA) safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: Central DXA lumbar spine and hip — inpatient rheumatology unit
- Indication: Glucocorticoid-induced bone loss monitoring; rheumatoid arthritis on prednisone 7.5 mg daily
- Timing: Scheduled 1400; patient took calcium citrate with lunch today
- Related orders: BMP, vitamin D level; denosumab discussion pending DXA
- Result: Prior DXA 18 months ago: T-score −1.9 lumbar spine; today’s scan pending
- Trend / prior value: Reports 1.5 cm height loss; intermittent thoracic stiffness; no neurologic deficits
- Pending tests: Formal T-score report and rheumatology treatment plan
- Vital signs: T 36.6 °C, HR 78/min, BP 132/70, RR 14, SpO₂ 97% on room air
- Symptoms: Mild thoracic stiffness; ambulates with walker; denies leg weakness
- Focused assessment: Mild kyphosis; unsteady gait with walker; right total hip arthroplasty
- Preparation notes: Calcium citrate taken at noon; metal walker not removed at bedside; IV contrast CT 8 days ago
- Collection events: Sent to scan without escort despite walker; hip prosthesis not communicated to radiology
- Teaching gaps / safety concerns: Calcium within 24 h; recent contrast; fall risk; unilateral hip hardware
Answer key & rationale
Frequently Asked Questions
FAQ
What is dual-energy X-ray absorptiometry (DEXA) used for?
DEXA measures bone mineral density, most often at the lumbar spine and hip, to classify low bone mass and estimate osteoporosis-related fracture risk using international health authorities T-score categories when combined with clinical factors.
How is DXA different from a standard X-ray?
Routine X-rays show anatomy and fractures but do not quantify BMD as accurately as DXA. DEXA uses two X-ray energy levels to calculate density for osteoporosis screening and monitoring.
Why should calcium supplements be held before DXA?
Official patient guidance recommends not taking calcium supplements for at least 24 hours before DXA because ingested calcium can artifact lumbar spine measurements and reduce accuracy.
What do T-score and Z-score mean on a DXA report?
T-score compares BMD to a healthy young adult reference (international health authorities: −1.0 or above normal; between −1.0 and −2.5 low bone mass; −2.5 or below osteoporosis). Z-score compares to age-matched peers and may prompt secondary osteoporosis workup when markedly low in younger adults.
Is fasting required before DXA?
Routine central DXA usually does not require fasting — patients may eat normally on the day of the exam per standard clinical references. Specialized body-composition protocols may require overnight fasting per local policy.
Can pregnant patients have DXA?
Patients should tell the team if pregnancy is possible. Although DXA uses low-dose radiation, pregnancy status should be assessed and scanning deferred or modified per institutional policy when pregnancy is confirmed or cannot be excluded.
Does a normal DXA result rule out fractures?
No. DXA estimates fracture risk from BMD but does not diagnose all fractures. Vertebral fractures may be present with minimal symptoms, and clinical assessment remains essential.
References
References
-
Radiological Society of North America. Bone Density Scan (DEXA or DXA). RadiologyInfo.org; reviewed 2024.https://www.radiologyinfo.org/en/info/dexa
-
U.S. National Library of Medicine. Bone mineral density test. MedlinePlus.https://medlineplus.gov/ency/article/007197.htm
-
U.S. Preventive Services Task Force. Osteoporosis to Prevent Fractures: Screening. JAMA. 2018;319(24):2521–2531.https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis Overview. NIH.https://www.niams.nih.gov/health-topics/osteoporosis
-
National Institute for Health and Care Excellence. Osteoporosis: assessing the risk of fragility fracture. NICE Guideline CG146.https://www.nice.org.uk/guidance/cg146
-
International Society for Clinical Densitometry. Official Positions. ISCD.https://iscd.org/learn/official-positions/
-
National Health Service. Bone density scan (DEXA scan). NHS.uk.https://www.nhs.uk/conditions/dexa-scan/
-
Dual-Energy X-Ray Absorptiometry. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.https://www.ncbi.nlm.nih.gov/books/NBK519042/
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Dual-Energy X-ray Absorptiometry (DEXA).
Policies: Medical Review Process · Editorial Policy · Correction Policy